Cancer researcher Chi Van Dang studies pharmacokinetics—the way the body absorbs, distributes, metabolizes, and excretes a drug at different times of day. His work on treatment timing holds promise for improving patient outcomes.| The Hub
First-of-its-kind therapy developed by Johns Hopkins researchers cleared for treatment of Barth syndrome, a condition that causes muscle weakness, an enlarged heart, and shortened life expectancy| The Hub
This article has been deidentified to protect the anonymity and confidentiality of the patient in the story. Any matches in names or circumstances to other patients are entirely coincidental. It’s early in intern year, and I’m a new "baby doctor". My mind is algorithmically checking off the boxes as I read the morning lab values:… Read More »Learning to Read The post Learning to Read first appeared on Biomedical Odyssey.| Biomedical Odyssey
Research Saves Lives storytelling highlights the lifesaving treatments and scientific breakthroughs made possible by federally funded research at Johns Hopkins University| The Hub
